Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

27
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
27
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

31
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
31
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

473
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
473
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

152
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
152
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

44
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
44
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

178
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An interactive tool to identify existing evidence and research gaps on agricultural production processes to address heavy metals in foods: developed from a scoping review.

Critical reviews in food science and nutrition·2026
Same author

Probabilistic Concentration-Response Modeling and Risk Prioritization of Defined Mixtures of PFAS Using Human <i>In Vitro</i> Assays.

Environmental science & technology·2026
Same author

New Frontiers of Drug Development Through the Use of New Approach Methodologies.

The AAPS journal·2026
Same author

A Deep Learning-Based Scoring Framework for Large-Scale Multi-Donor Cardiotoxicity Screening.

bioRxiv : the preprint server for biology·2026
Same author

Insights into complementary exposomic targeted analysis and suspect screening approaches: a case study examining human serum for chemicals with LC-IMS-MS.

Environmental science. Advances·2026
Same author

Human vs. cells vs. machine: A comparative analysis of toxicological points of departure derived from quantitative read-across (qRAx), in vitro data, and In silico predictions.

Regulatory toxicology and pharmacology : RTP·2026

Related Experiment Video

Updated: Oct 23, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K

A new approach method for characterizing inter-species toxicodynamic variability.

Sarah D Burnett1, Moumita Karmakar2, William J Murphy1

  • 1Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.

Journal of Toxicology and Environmental Health. Part A
|August 24, 2021
PubMed
Summary
This summary is machine-generated.

This study used an in vitro model with dermal fibroblasts from diverse species to assess cytotoxicity variability. Findings show both inter-species and inter-individual differences impact toxicity, paving the way for improved risk assessment.

Keywords:
Risk assessmentcytotoxicityin vitro methodsmodeling

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

12.8K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.4K

Related Experiment Videos

Last Updated: Oct 23, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

12.8K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.4K

Area of Science:

  • Toxicology
  • In vitro toxicology
  • Risk assessment

Background:

  • Inter-species differences in toxicodynamics introduce uncertainty in safety evaluations, often managed with default adjustment factors.
  • In vitro studies using cells from different species have shown promise for predicting sensitivity to cytotoxicity but haven't been fully evaluated for risk assessment.
  • The utility of in vitro models for characterizing variability in toxicodynamics remains underexplored.

Purpose of the Study:

  • To test the hypothesis that an in vitro model using dermal fibroblasts from diverse species and individuals can inform inter-species and inter-individual variability in toxicodynamics.
  • To characterize both inter-species and inter-individual variability in cytotoxicity using a standardized screening approach.
  • To evaluate the potential of in vitro methods to replace default adjustment factors in risk assessment.

Main Methods:

  • Conducted concentration-response cytotoxicity screening of 40 diverse chemicals.
  • Utilized primary dermal fibroblasts from 68 individuals across 54 species, including humans, mammals, and birds.
  • Examined a range of chemicals including drugs, environmental pollutants, and food/flavor/fragrance agents.

Main Results:

  • Demonstrated that both inter-species and inter-individual variability contribute significantly to differences in cytotoxicity sensitivity.
  • Revealed that the magnitude of these variability components is chemical-dependent.
  • Showed that the in vitro model effectively characterized toxicodynamic variability across species and individuals.

Conclusions:

  • This study supports a paradigm shift towards higher-throughput in vitro approaches in risk assessment, moving away from traditional in vivo toxicity testing.
  • The findings advocate for replacing default adjustment factors with experimental characterization of toxicodynamic variability.
  • The developed in vitro model offers a viable strategy to address both inter-species and inter-individual toxicodynamic variability in chemical safety evaluations.